Showing results (131-140 of 315) with videos related to

Sort By:
Pageof 32
Gut and Liver|March 10, 2023
Cellular and Molecular Mechanisms of Intestinal FibrosisXiaomin Wu, Xiaoxuan Lin, Jinyu Tan, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2014
[Clinical characteristics and risk factors of refractory Crohn's disease]Pingping Xu, Yao He, Baili Chen, et al.
Gastroenterology Report|July 5, 2022
Development and validation of a nomogram to predict indolent course in patients with ulcerative colitis: a single-center retrospective studyNa Li, Shukai Zhan, Caiguang Liu, et al.
International Journal of Cancer|November 12, 2009
Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancerXiaoqin Wu, Zhirong Zeng, Bin Chen, et al.
Oncotarget|January 7, 2017
Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancerYi Lin, Ertao Zhai, Bing Liao, et al.
Neuroendocrinology|October 23, 2019
Quantitative Pretreatment CT Parameters as Predictors of Tumor Response of Neuroendocrine Tumor Liver Metastasis to Transcatheter Arterial Bland EmbolizationYiming Liu, Wenchuan Chen, Wei Cui, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 24, 2023
Validation of disease severity index for predicting complicated disease in Crohn's disease: A comparison study with Lémann indexYun Qiu, Longyuan Zhou, Baolan Lu, et al.
Future Oncology (London, England)|July 19, 2018
Analysis of risk factors of lymph node metastasis in rectal neuroendocrine neoplasms using multicenter dataGengzhou Wei, Xingyu Feng, Wei Wang, et al.
Cancer Medicine|March 15, 2022
Prolonged progression-free survival achieved by octreotide LAR plus transarterial embolization in low-to-intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burdenYiming Liu, Haikuan Liu, Wenchuan Chen, et al.
Journal of Advanced Research|July 6, 2025
Transglutaminase 2 modulates inflammatory angiogenesis via vascular endothelial growth factor receptor 2 pathway in inflammatory bowel diseaseGaoshi Zhou, Mudan Zhang, Shuhui Zheng, et al.
Pageof 32